标题
Attention-enhancing effects of propranolol and synergistic effects with nicotine
作者
关键词
-
出版物
COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-14
DOI
10.3758/s13415-020-00794-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Distinct Roles of Dopamine and Noradrenaline in Incidental Memory
- (2019) Tobias U. Hauser et al. JOURNAL OF NEUROSCIENCE
- Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects
- (2019) Britta Hahn et al. PSYCHOPHARMACOLOGY
- Neuropsychopharmacological regulation of performance on creativity-related tasks
- (2018) David Q Beversdorf Current Opinion in Behavioral Sciences
- Norepinephrine at the nexus of arousal, motivation and relapse
- (2016) Rodrigo A. España et al. BRAIN RESEARCH
- Temperament and arousal systems: A new synthesis of differential psychology and functional neurochemistry
- (2016) Irina Trofimova et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- A test of the cognitive-enhancing potential of low-dose mecamylamine in healthy non-smokers
- (2016) Marie B. Yuille et al. PSYCHOPHARMACOLOGY
- A Test of the Cognitive Self-Medication Hypothesis of Tobacco Smoking in Schizophrenia
- (2013) Britta Hahn et al. BIOLOGICAL PSYCHIATRY
- Nicotinic acetylcholine receptors: From basic science to therapeutics
- (2012) Raymond Hurst et al. PHARMACOLOGY & THERAPEUTICS
- A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia
- (2011) Victoria C. Wing et al. Annals of the New York Academy of Sciences
- Serotonin antagonists in the five-choice serial reaction time task and their interactions with nicotine
- (2011) Davide Quarta et al. BEHAVIOURAL PHARMACOLOGY
- Functional brain imaging of nicotinic effects on higher cognitive processes
- (2011) Paul A. Newhouse et al. BIOCHEMICAL PHARMACOLOGY
- ACHRNA5allele related to nicotine addiction and schizophrenia
- (2011) L. E. Hong et al. GENES BRAIN AND BEHAVIOR
- Neuronal Nicotinic Acetylcholine Receptors - Targets for the Development of Drugs to Treat Cognitive Impairment Associated with Schizophrenia and Alzheimers Disease
- (2010) Simon Haydar et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography
- (2010) Kai Kendziorra et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Sensorimotor Gating is Associated with CHRNA3 Polymorphisms in Schizophrenia and Healthy Volunteers
- (2010) Nadine Petrovsky et al. NEUROPSYCHOPHARMACOLOGY
- Meta-analysis of the acute effects of nicotine and smoking on human performance
- (2010) Stephen J. Heishman et al. PSYCHOPHARMACOLOGY
- Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition
- (2009) Hans Rollema et al. BIOCHEMICAL PHARMACOLOGY
- Treating the Cognitive Deficits of Schizophrenia with Alpha4Beta2 Neuronal Nicotinic Receptor Agonists
- (2009) Richard Radek et al. CURRENT PHARMACEUTICAL DESIGN
- Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function
- (2009) Christopher J. Edgar et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now